Exousia Pro Will Launch a Web Series with Our New Consultant
30 Apr 2025 //
ACCESSWIRE
Exousia Pro Ends Glioblastoma Trial Early for Drug Filing
29 Apr 2025 //
ACCESSWIRE
Exousia Pro CSO Reveals Significant Glioblastoma Study Findings
21 Apr 2025 //
ACCESSWIRE
Exousia Pro Offers Guidance on New Subdivisions
17 Apr 2025 //
ACCESSWIRE
Exousia Pro to Deliver 500B Dried Exosomes for Trade Show
08 Apr 2025 //
ACCESSWIRE
Exousia Pro Issues Update on Name Change
03 Apr 2025 //
ACCESSWIRE
Exousia Pro Has Appointed Matthew Dwyer As Its New President
02 Apr 2025 //
ACCESSWIRE
Exousia Pro Begins Production of Plant-Based Exosomes
25 Mar 2025 //
ACCESSWIRE
Exousia Has Successfully Renegotiated Its License Agreement
18 Mar 2025 //
ACCESSWIRE
Marijuana Completes Acquisition of Exousia AI
06 Jan 2025 //
PR NEWSWIRE